Biomarker ID | 636 |
PMID | 21504578 |
Year | 2011 |
Biomarker | 40S ribosomal protein S8; Heterogeneous nuclear ribonucleoprotein H; 78 kDa glucose-regulated protein; Cytochrome c oxidase polypeptide VIc; Cytochrome c oxidase subunit 5B, mitochondrial ATP synthase subunit beta, mitochondrial Stress-70 protein, mitochondrial Biglycan; Elongation factor Tu mitochondrial; Ubiquitin-like modifier-activating enzyme 1; Protein disulfide-isomerase A4; Heterochromatin protein 1-binding protein 3; Tumor protein D52 Prohibitin-2; Protein disulfide-isomerase; EH domain-containing protein 2; 60 kDa heat shock protein mitochondrial; Nucleophosmin Periostin; Sorbitol dehydrogenase |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Tissue |
Subjects | Humans |
Regulation | Upregulated in PCA(Fold Change) : |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | Prostate Cancer Vs BPH |
Type of Biomarker | Diagnostic |
Cohort | Patients undergoing prostate Biopsies were divided into 3 groups, PCA (n=20), BPH (n=20) and PIN (n=10) |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.05 |
Method Used | iTRAQ |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | RPS8, HNRNPH1, HSPA5, COX6C, COX5B, ATP5F1B, HSPA9, BGN, TUFM, UBA1, PDIA4, HP1BP3, TPD52, P4HB, EHD2, HSPD1, POSTN, SORD |